SHAREHOLDER ALERT: WeissLaw LLP Reminds XLRN, JMP, ECHO, and KDMN Shareholders About Its Ongoing Investigations Pharmaceutical Investing
BRISTOL MYERS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY Biotech Investing
Health Canada Approves the Use of RINVOQ® for the Treatment of Adults and Adolescents with Moderate to Severe Atopic Dermatitis Biotech Investing
AbbVie's RINVOQ® Met Primary and All Ranked Secondary Endpoints in Phase 3 Study in Ankylosing Spondylitis Biotech Investing
Bristol Myers Squibb Provides Update on Phase 2 Study of Deucravacitinib in Patients With Moderate to Severe Ulcerative Colitis Biotech Investing
InvestmentPitch Media Video Discusses Love Pharma's Appointment of Joshua Maurice as its Chief Operating Officer - Video Available on Investmentpitch.com Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Home BancShares, Valley National, Kraton Corporation, and Acceleron Pharma on behalf of Stockholders and Encourages Investors to Contact the Firm Pharmaceutical Investing
Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature Medical Device Investing
Numinus to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th Cannabis Investing News
Lobe Announces Krysalis VX Innovations Inc., a Company Equally Owned by Lobe Sciences Ltd. and Virtual Psychedelics Incorporated, Appointment of Interdisciplinary Team of Advisors Cannabis Investing News
